Portfolio Spotlight Ep 2: Doctor Anywhere with Founder & CEO, Wai Mun Lim
Did you know Doctor Anywhere, Singapore’s leading telemedicine provider, began with only 4 employees in 2017? ⏩ Fast forward six years, they have transformed
- 30 01 2024
- |
All
Stories & Videos
Insights & Trends
Portfolio News
Announcements
E-Newsletters
Events
Tab Item Content
Discover Stories
Portfolio Spotlight Ep 2: Doctor Anywhere with Founder & CEO, Wai Mun Lim
- 30 01 2024
- |
Revolutionising Insurtech: Rob Schimek, CEO of Bolttech, on the Power of Connection
- 10 10 2023
- |
Discover Insights and Trends
A recipe for success: How to thrive in Southeast Asia alternative protein market
- 11 07 2023
- |
What to watch in the biomedical space over the next five years
- 23 02 2023
- |
Enhancing the development of the ASEAN markets and accelerating global market expansion for Chinese biopharma companies
- 20 12 2020
- |
Racing toward the future: Artificial Intelligence in Southeast Asia
- 08 10 2020
- |
Discover Portfolio News
ArteraAI Secures $20 Million in Funding to Further Personalize Cancer Therapy With Multimodal AI
- 01 02 2024
- |
AI market intelligence platform AlphaSense snags strategic investment from EDBI
- 18 01 2024
- |
Endeavor BioMedicines Enters License Agreement with Hummingbird Bioscience for Worldwide Rights to HMBD-501, a Next Generation HER3-Targeted Antibody-Drug Conjugate (ADC)
- 19 10 2023
- |
EDBI-Backed Singapore Fintech Startup Thunes Wants To Take On SWIFT
- 04 08 2023
- |
Singapore-headquartered Mirxes secures US$50 mil in Series D funding; files listing application with HKEx
- 26 07 2023
- |
Ambiq Achieves Milestone of Powering Over 200 Million IoT Devices
- 13 07 2023
- |
EdgeQ Closes $75M Series-B Investment and Ramps to Customers’ Demand for Its Award-Winning 5G+AI Base Station-on-a-Chip for 5G Networks
- 02 05 2023
- |
Proxtera announces successful first close, of Series Seed round of funding with Ant Group, CerraCap Ventures, and EDBI
- 30 03 2023
- |
Resolve Biosciences Secures $71 Million Series B Financing to Accelerate Commercial Expansion
- 24 10 2022
- |
ImmunoScape Raises $14M to Facilitate the Discovery and Characterization of Cancer-Specific T-cell Receptors
- 20 09 2022
- |
Fazz Secures $100M in Series C to Power Financial Inclusion in SEA
- 14 09 2022
- |
Discover Announcements
EDBI Commemorates 30 Years of Investing to Shape Singapore’s Future
- 02 12 2021
- |
Discover E-Newsletters
EDBI continuing to invest in exciting digital health, biotech and fintech companies in Q4 2019
- 04 04 2019
- |